TriSalus Life Sciences, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
TriSalus Life Sciences, Inc. (TLSI) reported Adjustments to Additional Paid in Capital, Warrant Issued of $11.92 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-05
- TriSalus Life Sciences, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-06-30 was $11.92M.
- TriSalus Life Sciences, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $11.92M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 4 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|
| 2024-12-31 | $11.92M 10-K · filed 2026-03-05 | ||
| 2024-06-30 | $11.92M 10-Q · filed 2025-11-13 | ||
| 2020-12-31 | $1.92M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |